A detailed history of Lm Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Lm Advisors LLC holds 9,249 shares of MRNA stock, worth $373,937. This represents 0.13% of its overall portfolio holdings.

Number of Shares
9,249
Previous 8,749 5.71%
Holding current value
$373,937
Previous $1.04 Million 40.52%
% of portfolio
0.13%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$63.64 - $125.14 $31,820 - $62,570
500 Added 5.71%
9,249 $618,000
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $303 - $499
-3 Reduced 0.03%
8,749 $1.04 Million
Q1 2024

May 15, 2024

SELL
$85.37 - $115.44 $196,351 - $265,512
-2,300 Reduced 20.81%
8,752 $933,000
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $768,224 - $1.15 Million
11,052 New
11,052 $1.1 Billion

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15.8B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Lm Advisors LLC Portfolio

Follow Lm Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lm Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lm Advisors LLC with notifications on news.